Status: Recruiting
A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee
To evaluate the efficacy and safety of CLS2901C human allogenic chondrocyte sheets used in the osteotomy + RMSC group compared to in the osteotomy alone group of patients with osteoarthritis of the knee (OAK).
Participants needed: 96
Trial details
Phase: Phase 3Age: 20-79Biological sex: AllType: InterventionalSponsor: CellSeed Inc.Updated: Nov 24, 2025Locations: 6
Eligibility criteria
Male or female aged 20 to 79 years at informed consent. [+12]
Requires surgical treatment of the non-target knee during the study period. [+3]